Alkotinib

alkotinib · Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alkotinib, covering 2024-04-26 to 2024-04-26. Get the full timeline:

Most recent: Clinical Trial Update: Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib [Phase 2]

See pricing